Press Release Description

Global Artificial Intelligence (AI) Enabled Imaging Modalities Market likely to attain around 31% CAGR during 2021-26

According to the MarkNtel Advisors research report, Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Analysis, 2021,” The market is likely to grow at a CAGR of 31% during 2021-26 due to the surging complexities of datasets aiding the requirement for AI. Further, the rising number of medical imaging & radiology startups and the increasing adoption of AI-enabled Imaging in the healthcare sector help doctors do proper screening, assessments, and diagnoses, thereby propelling the market growth. Further, burgeoning investments in developing healthcare infrastructure and snowballing demand by professionals for better-quality & resolution to assist patients with disease-specific treatment are other primary factors driving the Artificial Intelligence (AI) Enabled Imaging Modalities Market growth across the globe.

Key questions answered in the study

  1. What are the current and future trends in the Global Artificial Intelligence (AI) Enabled Imaging Modalities market? 
  2. How has the industry been evolving in terms of geography and services adoption?
  3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers and challenges for the Global Artificial Intelligence (AI) Enabled Imaging Modalities market?
  5. What are the customer orientation, purchase behavior, and expectations from the Global Artificial Intelligence (AI) Enabled Imaging Modalities market service providers across various regions? 

Services Segment Exhibits Fastest Growth

Within the Component Segment, the market segments into Software, Hardware, and Services. Of these segments, Services are likely to grow significantly during the forecast period due to the mounting demand for the continuous flow of data between people and devices, which enhances the security & efficiency of medical devices, and, in turn, improves decision-making in real-time. Moreover, rising awareness regarding advanced technologies and application programming interfaces among healthcare experts also fuels the Services segment, thereby propelling the overall growth of the Global Artificial Intelligence (AI) Enabled Imaging Modalities market.

“Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for AI-enabled Imaging Modality providers across the globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings.    

Asia-Pacific Exhibits Fastest Growth

The Asia-Pacific region is likely to register the fastest growth in the Global Artificial Intelligence (AI) Enabled Imaging Modalities market during 2021-26 due to increasing government initiatives to encourage healthcare providers to adopt AI-based imaging modalities. Further, surging initiatives by private companies to have better systems and cost reduction techniques are other crucial factors likely to propel the use of AI-enabled imaging modalities in the region.

Moreover, the increasing demand for e-diagnostic services in the healthcare industry shall also contribute to the market growth in the forecast period, reveals MarkNtel Advisors in their research report, “Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Analysis, 2021.” According to MarkNtel Advisors, the leading market players in the Global Artificial Intelligence (AI) Enabled Imaging Modalities Market are Arterys, Voxel Cloud, Butterfly Network, Infervision, Gauss Surgical, Owkin, Zebra Medical Vision, Curemetrix, Cellmatiq, and Lunit.

Market Segmentation:

  1. By Component (Software [AI Software Algorithms, Real-Time Medical Imaging, Image Analysis, Predictive Analysis Solution, Intelligent Algorithms For Image Analysis, Data Mining Techniques], Hardware [Processor {GPU, PU, ASIC, FPGA} Network, By Memory], Services [Installation, Support & Maintenance, Others])
  2. By Therapeutic Application (Cardiology, Oncology [Breast Cancer, Lung Cancer, Other cancer types], Neurology, Pulmonology, Others)
  3. By Modality (Computed Tomography (CT), Magnetic Resonance (MR), Ultrasound, X-Ray, Positron Emission Tomography (PET), Other Modalities) 
  4. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
  5. By Country (U.S, Canada, Brazil, Germany, France, The U.K, Spain, Russia, China, India, Japan, UAE, Israel)
  6. By Competitors (Arterys, Voxel cloud, Butterfly network, Infervision, Gauss Surgical, Owkin, Zebra Medical Vision, Curemetrix, Cellmatiq, MedyMatch, BrainerMiner, Lunit)